°ÄÃÅÀúÊ·¿ª½±¼Ç¼

XClose

UCL Queen Square Institute of Neurology

Home
Menu

Publications and impact

See also REF 2021 ²¹²Ô»åÌýWhy Study with usÌýfor further examples of research excellence and impact.

REF graphic research power
  • In the calendar year 2023, Institute staff published 1828Ìýpapers; 77Ìýwere published in the top 50 of all scientific journals (ranked by ESI impact factors), including Nature, Science, Lancet ²¹²Ô»åÌýBMJ.Ìý
  • 12Ìýof our professors are named as being among the most influential academics in the worldÌý(Clarivate Web of Science’s ‘Highly Cited Researchers 2022’). Please seeÌýour news itemÌýfor further details.
  • Impact case studiesÌý(from theÌýwebsite)
  • #MadeAtUCL campaign ground-breaking research and discoveries

Please see for a list of departmental publications by year. You can also search for specific authors, titles etc within UCL Discovery.ÌýPublication data for individuals within the Department is also available within their

Ìý

UCL ranked as a leader in academic-corporate and academic collaborations inÌýAlzheimer's research

Elsevier has published a new metric for Alzheimer’s research, which finds that °ÄÃÅÀúÊ·¿ª½±¼Ç¼is #3 in the world for Alzheimer’s research (2013-2018), while also being a leader in academic-corporate and academic collaborations.ÌýElsevier’s report entitledÌýAlzheimer’s Disease Research Insights: Impact, Trends, OpportunitiesÌýfinds:

  • UCLÌýis amongst the top three global institutions for scholarly output on Alzheimer’s research between 2013-2018, with Harvard University and the Institut National de la Santé et de la Recherche Médicale narrowly above. This makes UCL the leading institution for Alzheimer’s research output in the UK.
  • Globally, Elsevier’s report finds that °ÄÃÅÀúÊ·¿ª½±¼Ç¼is the top university for academic-corporate collaborations in Alzheimer’s research, with 15.2% of UCL research involving a corporate.
  • °ÄÃÅÀúÊ·¿ª½±¼Ç¼is the second most prolific institution for international academic collaborations (75.7% of UCL’s output of research in Alzheimer’s disease between 2013-2018).

    RAND report shows th°ÄÃÅÀúÊ·¿ª½±¼Ç¼ has the highest share of highly cited publications in Neurology in England

    An independent report by RAND (2015) which examined highly-cited research, i.e. research publications falling into the top 20% for citations in their year and field, showed th°ÄÃÅÀúÊ·¿ª½±¼Ç¼ has the highest share of Highly Cited Publications (HCPs) in Neuroimaging (21.1%), Neurosciences (18.1%) andÌýClinical neurology (15.6%) and in the Dementias Highlight Area (15.5%) – in all cases significantly more than the nearest competitor.

    Neuroimaging is one of only two subject areas covered in the analysis where one HEI has over 20% of all HCPs

    Ìý